Sibakalzin is a drug used to treat osteoporosis, hypercalcemia, diseases associated with disorders of bone metabolism (Paget's disease).
**Composition of the drug**
The main active ingredient of the drug is calcium-regulating peptide, or parathyroid hormone, produced by the cells of the inner part of the mucous membrane of the thyroid gland (cystanoxol) - calcitonin. Accordingly, the pharmacological group of the drug is drugs that correct the metabolism of bone and other tissues.
**Release forms** Calcitonin is produced under different names, supplied in tablets or granules for the production of 5 mg suspensions according to the instructions. The packaging contains instructions for use. It is also used in solution form for injection intravenously or subcutaneously. Preparations with the active substance mixed with an acid or solvent that stabilizes its properties are also produced in convenient-to-use bottles according to